Details of the Drug Combinations

General Information of This Drug (ID: DM29M30)

Drug Name

Diosmin DM29M30

Synonyms

D3908

Indication

Disease Entry	ICD 11	Status	REF
Hemorrhoids	DB60	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

4 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Diosmin + Ruxolitinib	DCOX3K6	Ruxolitinib	Hodgkin lymphoma (Cell Line: L-1236)	[2]
Diosmin + Panobinostat	DCGQR6N	Panobinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
Diosmin + Marizomib	DCRJ5JE	Marizomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
Diosmin + Idarubicin	DC3BTUN	Idarubicin	Glioblastoma? (Cell Line: T98G)	[2]
------------------------------------------------------------------------------------

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Diosmin + Rivaroxaban	DCKQAM0	Rivaroxaban	Deep Vein Thrombosis	[3]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3	ClinicalTrials.gov (NCT03413618) Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis